Correction to: Oncogene (2015) 00, 1–11; doi:10.1038/onc.2015.446; published online 30 November 2015
Following the online publication of this article, it was noted that the final word ‘signalling’ had been erroneously missed off the title. The title has now been rectified.
The authors apologise for any inconvenience caused by this error.
This error has now been rectified, and the corrected article appears in this issue. The html and online pdf versions have also been rectified, and now carry the corrected paper.
Additional information
The online version of the original article can be found at 10.1038/onc.2015.446
Rights and permissions
About this article
Cite this article
Wang, G., Yu, Y., Sun, C. et al. Erratum: STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling. Oncogene 35, 4422 (2016). https://doi.org/10.1038/onc.2016.145
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2016.145
This article is cited by
-
STAT3 is critical for skeletal development and bone homeostasis by regulating osteogenesis
Nature Communications (2021)
-
Insulin/IGF-1 signaling promotes immunosuppression via the STAT3 pathway: impact on the aging process and age-related diseases
Inflammation Research (2021)
